BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9776532)

  • 21. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea.
    Jo EK; Kim HS; Lee MY; Iseki M; Lee JH; Song CH; Park JK; Hwang TJ; Kook H
    J Korean Med Sci; 2002 Feb; 17(1):116-20. PubMed ID: 11850600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of X-linked immunodeficiency with hyper-IgM and X-linked lymphoproliferative syndrome.
    Notarangelo LD; Mantuano E; Bione S; Gimbo E; Giliani S; Caraffini A; Purtilo D; Farr C; Ugazio AG; Toniolo D
    Immunodeficiency; 1993; 4(1-4):225-9. PubMed ID: 8167706
    [No Abstract]   [Full Text] [Related]  

  • 23. Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome.
    Chang MW; Romero R; Scholl PR; Paller AS
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):191-6. PubMed ID: 9486673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of CD40-CD154 interactions on the expressed human V(H) repertoire: analysis of V(H) genes expressed by individual B cells of a patient with X-linked hyper-IgM syndrome.
    Brezinschek HP; Dörner T; Monson NL; Brezinschek RI; Lipsky PE
    Int Immunol; 2000 Jun; 12(6):767-75. PubMed ID: 10837404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case].
    Rodríguez C; Carrión F; Marinovic MA; Chávez E; Preisler J; Pooley F; Futatani T; Ochs HD
    Rev Med Chil; 2003 Mar; 131(3):303-8. PubMed ID: 12790080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo mutation causing X-linked hyper-IgM syndrome: a family study in Taiwan.
    Ma YC; Lee WI; Shyur SD; Lin SC; Huang LH; Wu JY
    Asian Pac J Allergy Immunol; 2005 Mar; 23(1):53-9. PubMed ID: 15997875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological reconstitution by allogeneic bone marrow transplantation in a child with the X-linked hyper-IgM syndrome.
    Kawai S; Sasahara Y; Minegishi M; Tsuchiya S; Fujie H; Ohashi Y; Kumaki S; Konno T
    Eur J Pediatr; 1999 May; 158(5):394-7. PubMed ID: 10333122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
    Bhushan A; Covey LR
    Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
    Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
    J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS commentary. Toxoplasmic encephalitis.
    Luft BJ; Remington JS
    J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM.
    Bordigoni P; Auburtin B; Carret AS; Schuhmacher A; Humbert JC; Le Deist F; Sommelet D
    Bone Marrow Transplant; 1998 Dec; 22(11):1111-4. PubMed ID: 9877275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome.
    Minegishi Y; Lavoie A; Cunningham-Rundles C; Bédard PM; Hébert J; Côté L; Dan K; Sedlak D; Buckley RH; Fischer A; Durandy A; Conley ME
    Clin Immunol; 2000 Dec; 97(3):203-10. PubMed ID: 11112359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS).
    Potasman I; Resnick L; Luft BJ; Remington JS
    Ann Intern Med; 1988 Jan; 108(1):49-51. PubMed ID: 3337515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brain toxoplasmosis: from a case disclosing AIDS. Recall of diagnostic, developmental and therapeutic elements].
    Jourdan C; Guérin JM; Artru F; Lamy B; Grau A; Huppert J; Pialat J; Etienne J
    Neurochirurgie; 1986; 32(3):248-53. PubMed ID: 3762838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
    Bhushan A; Barnhart B; Shone S; Song C; Covey LR
    J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the genetic defect in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1) to the CD40 ligand gene.
    Fuleihan R; Ramesh N; Rosen FS; Geha RS
    Trans Assoc Am Physicians; 1993; 106():91-5. PubMed ID: 7518624
    [No Abstract]   [Full Text] [Related]  

  • 37. [Type 1 hyper-IgM syndrome diagnosed in a 28-year-old patient with recurrent infections since childhood].
    Koike M; Oshimi K; Agematu K; Futani T
    Rinsho Ketsueki; 2006 Oct; 47(10):1377-80. PubMed ID: 17094577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A delayed diagnosis of X-linked hyper IgM syndrome complicated with toxoplasmic encephalitis in a child: A case report and literature review.
    Liu X; Zhou K; Yu D; Cai X; Hua Y; Zhou H; Wang C
    Medicine (Baltimore); 2017 Dec; 96(49):e8989. PubMed ID: 29245273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated cytomegalovirus infection as initial manifestation of hyper-IgM syndrome in a 15-month-old boy.
    Benesch M; Pfleger A; Eber E; Orth U; Zach MS
    Eur J Pediatr; 2000 Jun; 159(6):453-5. PubMed ID: 10867853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome.
    Kato T; Tsuge I; Inaba J; Kato K; Matsuyama T; Kojima S
    Bone Marrow Transplant; 1999 May; 23(10):1081-3. PubMed ID: 10373076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.